000			01952 a2200481 4500
005			20250516121654.0
264		0	_c20130715
008			201307s 0 0 eng d
022			_a1557-3265
024	7		_a10.1158/1078-0432.CCR-12-1063 _2doi
040			_aNLM _beng _cNLM
100	1		_aSingh, Jagdeep K
245	0	0	_aTargeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms. _h[electronic resource]
260			_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2013
300			_a643-56 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCell Line, Tumor
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aInterleukin-8 _xmetabolism
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplastic Stem Cells _xmetabolism
650	0	4	_aRNA Interference
650	0	4	_aReceptor, ErbB-2 _xantagonists & inhibitors
650	0	4	_aReceptors, Interleukin-8A _xantagonists & inhibitors
650	0	4	_aReceptors, Interleukin-8B _xantagonists & inhibitors
650	0	4	_aSignal Transduction
650	0	4	_aSpheroids, Cellular
650	0	4	_aTumor Cells, Cultured
700	1		_aFarnie, Gillian
700	1		_aBundred, Nigel J
700	1		_aSimões, Bruno M
700	1		_aShergill, Amrita
700	1		_aLandberg, Göran
700	1		_aHowell, Sacha J
700	1		_aClarke, Robert B
773	0		_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 19 _gno. 3 _gp. 643-56
856	4	0	_uhttps://doi.org/10.1158/1078-0432.CCR-12-1063 _zAvailable from publisher's website
999			_c22261959 _d22261959